Federal court rejects PhRMA challenge to Medicare drug price negotiation
A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer.
The U.S.
Court of Appeals for the 5th Circuit affirmed a prior...
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on thehill.com — the content belongs to The Hill.
